Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioequivalence assessment: a pharmaceutical industry perspective

J Godbillon1, J M Cardot, J B Lecaillon

  • 1Laboratoires Ciba-Geigy, Centre de Bioanalyse et de Pharmacocinétique, Rueil Malmaison, France.

European Journal of Drug Metabolism and Pharmacokinetics
|April 1, 1996
PubMed
Summary

This paper explores bioequivalence, focusing on challenges like highly variable drugs and special populations. It discusses new approaches and solutions for drug development and post-marketing studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Better reproductive success of an invasive thistle than its native relative under pollinator exclusion.

Plant biology (Stuttgart, Germany)·2025
Same author

Responders to biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric observational real-life study.

Rhinology·2024
Same author

Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.

International journal of pharmaceutics·2024
Same author

[Use of mepolizumab in hypereosinophilic syndromes: The position and proposals of the national reference center for hypereosinophilic syndromes].

La Revue de medecine interne·2023
Same author

[GATA2 gene mutations: 3 cases].

La Revue de medecine interne·2022
Same author

Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department.

La Revue de medecine interne·2021

Area of Science:

  • Pharmacokinetics and Drug Development
  • Regulatory Science
  • Pharmaceutical Analysis

Background:

  • Bioequivalence studies are crucial for drug approval and post-marketing surveillance.
  • Ensuring drug product equivalence is vital for patient safety and therapeutic efficacy.
  • Traditional bioequivalence assessments face challenges with certain drug characteristics and populations.

Purpose of the Study:

  • To comprehensively review and discuss various aspects of bioequivalence.
  • To address challenges in bioequivalence studies, including highly variable drugs, food effects, and special populations.
  • To explore novel approaches and solutions in bioequivalence interpretation and methodology.

Main Methods:

  • Literature review and discussion of existing bioequivalence principles.

Related Experiment Videos

  • Analysis of specific scenarios: highly variable drugs, food-drug interactions, and diverse populations.
  • Exploration of alternative bioequivalence strategies, including in vitro data and literature-based assessments.
  • Discussion on the impact of analytical method sensitivity and specificity.

    • Main Results:

    • Identified challenges in bioequivalence for highly variable drugs, necessitating wider acceptance ranges or alternative solutions.
    • Highlighted the importance of bioequivalence for the final market image and understanding food effects.
    • Discussed bioequivalence considerations for special populations (children, non-Caucasians) and the use of in vitro data.
    • Emphasized the need for new approaches in bioequivalence interpretation and the limitations of inadequate analytical methods.

    Conclusions:

    • Bioequivalence assessment requires tailored approaches considering drug variability, population, and study context.
    • Innovative strategies and robust analytical methods are essential for accurate bioequivalence determination.
    • Addressing bioequivalence in diverse scenarios ensures the quality and efficacy of marketed drug products.